Deutsch English Français

Contact

EP3406719

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP3406719

EP3406719 - CALCINEURIN B HOMOLOGOUS PROTEIN 1 INHIBITORS AND THERAPEUTIC AND NON-THERAPEUTIC USES THEREOF [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 18.10.2019 Database last updated on 28.06.2024
Former	The application has been published Status updated on 26.10.2018
Most recent event Tooltip	18.10.2019	Application deemed to be withdrawn	published on 20.11.2019 [2019/47]
Applicant(s)	For all designated states Universität zu Köln Albertus-Magnus-Platz 50923 Köln / DE
	[2018/48]
Inventor(s)	01 / Wirth, Brunhilde Heinrich-Heine-Str. 46 53225 Bonn / DE
	02 / Janzen, Eva Wilhelm Bachhausstr. 23 50931 Köln / DE
	03 / Mendoza-Ferreira, Natalia Komödienstr. 48 50667 Köln / DE
	04 / Hosseinibarkooie, Seyyedmohsen Kapuzinerstr. 2 50737 Köln / DE
	[2018/48]
Representative(s)	Lahrtz, Fritz Patentanwälte Isenbruck Bösl Hörschler PartG mbB Prinzregentenstraße 68 81675 München / DE
	[N/P]
Former [2018/48]	Lahrtz, Fritz Isenbruck Bösl Hörschler LLP Patentanwälte Prinzregentenstrasse 68 81675 München / DE
Application number, filing date	17172826.4	24.05.2017
	[2018/48]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	EP3406719
	Date:	28.11.2018
	Language:	EN
	[2018/48]
Search report(s)	(Supplementary) European search report - dispatched on:	EP	14.11.2017
Classification	IPC:	C12N15/113, A61K31/7088	[2018/48]
	CPC:	C12N15/113 (EP); A61K31/713 (EP); C12N2310/11 (EP)
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/48]
Extension states	BA	Not yet paid
	ME	Not yet paid
Validation states	MA	Not yet paid
	MD	Not yet paid
Title	German:	INHIBITOREN VON HOMOLOGEM CALCINEURIN-B-PROTEIN 1 UND THERAPEUTISCHE UND NICHTTHERAPEUTISCHE VERWENDUNGEN DAVON	[2018/48]
	English:	CALCINEURIN B HOMOLOGOUS PROTEIN 1 INHIBITORS AND THERAPEUTIC AND NON-THERAPEUTIC USES THEREOF	[2018/48]
	French:	INHIBITEURS DE LA PROTÉINE 1 HOMOLOGUE DE CALCINEURINE B ET LEURS UTILISATIONS THÉRAPEUTIQUES ET NON THÉRAPEUTIQUES	[2018/48]
Examination procedure	29.05.2019	Application deemed to be withdrawn, date of legal effect [2019/47]
	13.06.2019	Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time [2019/47]
Fees paid	Penalty fee
	Additional fee for renewal fee
	31.05.2019	03 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[A]WO2015014838 (UNIVERSITÄT ZU KÖLN [DE]) [A] 1-9 * claims 1-15 *;
		[A]WO2015035460 (UNIV WESTERN AUSTRALIA [AU]) [A] 1-9 * paragraph [0011]; claims 1, 10, 19 *;
		[A] - LIN X ET AL, "Inhibition of calcineurin phosphatase activity by a calcineurin B homologous protein", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY, (19991217), vol. 274, no. 51, doi:10.1074/JBC.274.51.36125, ISSN 0021-9258, pages 36125 - 36131, XP002213293 [A] 1-9 * the whole document * DOI: http://dx.doi.org/10.1074/jbc.274.51.36125
		[A] - LIU J O ED - ANDREWS PETER W ET AL, "Endogenous protein inhibitors of calcineurin", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICAT, ELSEVIER, AMSTERDAM, NL, (20031128), vol. 311, no. 4, doi:10.1016/J.BBRC.2003.10.020, ISSN 0006-291X, pages 1103 - 1109, XP004472284 [A] 1-9 * the whole document * DOI: http://dx.doi.org/10.1016/j.bbrc.2003.10.020
	by applicant	- ACKERMANN, B.; S. KROBER; L. TORRES-BENITO; A. BORGMANN; M. PETERS; S.M. HOSSEINI BARKOOIE; R. TEJERO; M. JAKUBIK; J. SCHREML; J., "Plastin 3 ameliorates spinal muscular atrophy via delayed axon pruning and improves neuromuscular junction functionality", HUM MOL GENET., (2013), vol. 22, pages 1328 - 1347
		- ANDRADE, J.; H. ZHAO; B. TITUS; S. TIMM PEARCE; M. BARROSO., "The EF-hand Ca2+-binding protein p22 plays a role in microtubule and endoplasmic reticulum organization and dynamics with distinct Ca2+-binding requirements", MOL BIOL CELL, (2004), vol. 15, pages 481 - 496
		- BARROSO, M.R.; K.K. BERND; N.D. DEWITT; A. CHANG; K. MILLS; E.S. SZTUL., "A novel Ca2+-binding protein, p22, is required for constitutive membrane traffic", J BIOL CHEM., (1996), vol. 271, pages 10183 - 10187
		- BAUMGARTEL, K.; I.M. MANSUY, "Neural functions of calcineurin in synaptic plasticity and memory", LEARN MEM., (2012), vol. 19, pages 375 - 384
		- BODMER, D.; M. ASCANO; R. KURUVILLA, "Isoform-specific dephosphorylation of dynaminl by calcineurin couples neurotrophin receptor endocytosis to axonal growth", NEURON, (2011), vol. 70, doi:doi:10.1016/j.neuron.2011.04.025, pages 1085 - 1099, XP028379652 DOI: http://dx.doi.org/10.1016/j.neuron.2011.04.025
		- CLAYTON, E.L.; V. ANGGONO; K.J. SMILLIE; N. CHAU; P.J. ROBINSON; M.A. COUSIN, "The phospho-dependent dynamin-syndapin interaction triggers activity-dependent bulk endocytosis of synaptic vesicles", JNEUROSCI., (2009), vol. 29, pages 7706 - 7717
		- COOPER, J.D.; A. SALEHI; J.D. DELCROIX; C.L. HOWE; P.V. BELICHENKO; J. CHUA-COUZENS; J.F. KILBRIDGE; E.J. CARLSON; C.J. EPSTEIN; W, "Failed retrograde transport of NGF in a mouse model of Down's syndrome: reversal of cholinergic neurodegenerative phenotypes following NGF infusion", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, (2001), vol. 98, pages 10439 - 10444
		- COUSIN, M.A.; P.J. ROBINSON, "The dephosphins: dephosphorylation by calcineurin triggers synaptic vesicle endocytosis", TRENDS IN NEUROSCIENCES., (2001), vol. 24, doi:doi:10.1016/S0166-2236(00)01930-5, pages 659 - 665, XP004321959 DOI: http://dx.doi.org/10.1016/S0166-2236(00)01930-5
		- CROWE, J.; B.S. MASONE; J. RIBBE, "One-step purification of recombinant proteins with the 6xHis tag and Ni-NTA resin", MOLECULAR BIOTECHNOLOGY., (1995), vol. 4, doi:doi:10.1007/BF02779018, pages 247 - 258, XP002048291 DOI: http://dx.doi.org/10.1007/BF02779018
		- D'YDEWALLE, C.; D.M. RAMOS; N.J. PYLES; S.Y. NG; M. GORZ; C.M. PILATO; K. LING; L. KONG; A.J. WARD; L.L. RUBIN, "The Antisense Transcript SMN-AS1 Regulates SMN Expression and Is a Novel Therapeutic Target for Spinal Muscular Atrophy", NEURON, (2017), vol. 93, pages 66 - 79
		- DI SOLE, F.; K. VADNAGARA; O.W. MOE; V. BABICH, "Calcineurin homologous protein: a multifunctional Ca2+-binding protein family", AM J PHYSIOL RENAL PHYSIOL., (2012), vol. 303, pages F 165 - 179
		- DIMITRIADI, M.; J.N. SLEIGH; A. WALKER; H.C. CHANG; A. SEN; G. KALLOO; J. HARRIS; T. BARSBY; M.B. WALSH; J.S. SATTERLEE, "Conserved genes act as modifiers of invertebrate SMN loss of function defects", PLOS GENET., (2010), vol. 6, page E1001172
		- ERMAK, G.; T.E. MORGAN; K.J. DAVIES, "Chronic overexpression of the calcineurin inhibitory gene DSCR1 (Adapt78) is associated with Alzheimer's disease", J BIOL CHEM., (2001), vol. 276, doi:doi:10.1074/jbc.M102829200, pages 38787 - 38794, XP002969146 DOI: http://dx.doi.org/10.1074/jbc.M102829200
		- EVANS, G.J.; M.A. COUSIN, "Activity-dependent control of slow synaptic vesicle endocytosis by cyclin-dependent kinase 5", JNEUROSCI., (2007), vol. 27, pages 401 - 411
		- FELDKOTTER, M.; V. SCHWARZER; R. WIRTH; T.F. WIENKER; B. WIRTH, "Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy", AMERICAN JOURNAL OF HUMAN GENETICS, (2002), vol. 70, pages 358 - 368
		- FLANAGAN-STEET, H; M.A. FOX; D. MEYER; J.R. SANES, "Neuromuscular synapses can form in vivo by incorporation of initially aneural postsynaptic specializations", DEVELOPMENT, (2005), vol. 132, pages 4471 - 4481
		- HOSSEINIBARKOOIE, S.; M. PETERS; L. TORRES-BENITO; R.H. RASTETTER; K. HUPPERICH; A. HOFFMANN; N. MENDOZA-FERREIRA; A. KACZMAREK; E, "The Power of Human Protective Modifiers: PLS3 and COROIC Unravel Impaired Endocytosis in Spinal Muscular Atrophy and Rescue SMA Phenotype", AMERICAN JOURNAL OF HUMAN GENETICS, (2016), vol. 99, doi:doi:10.1016/j.ajhg.2016.07.014, pages 647 - 665, XP029711784 DOI: http://dx.doi.org/10.1016/j.ajhg.2016.07.014
		- HSIEH-LI, H.M.; J.G. CHANG; Y.J. JONG; M.H. WU; N.M. WANG; C.H. TSAI; H. LI, "A mouse model for spinal muscular atrophy", NAT GENET., (2000), vol. 24, doi:doi:10.1038/71709, pages 66 - 70, XP002153156 DOI: http://dx.doi.org/10.1038/71709
		- HUA, Y.; K. SAHASHI; F. RIGO; G. HUNG; G. HOREV; C.F. BENNETT; A.R. KRAINER, "Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model", NATURE, (2011), vol. 478, doi:doi:10.1038/nature10485, pages 123 - 126, XP055038358 DOI: http://dx.doi.org/10.1038/nature10485
		- JIMENEZ-VIDAL, M.; J. SRIVASTAVA; L.K. PUTNEY; D.L. BARBER, "Nuclear-localized calcineurin homologous protein CHP1 interacts with upstream binding factor and inhibits ribosomal RNA synthesis", JBIOL CHEM., (2010), vol. 285, pages 36260 - 36266
		- KAIFER, K.A.; E. VILLALON; E.Y. OSMAN; J.J. GLASCOCK; L.L. ARNOLD; D.D. CORNELISON; C.L. LORSON., "Plastin-3 extends survival and reduces severity in mouse models of spinal muscular atrophy", JCI INSIGHT., (2017), vol. 2, page E89970
		- KUBLER, E.; H. RIEZMAN, "Actin and fimbrin are required for the internalization step of endocytosis in yeast", EMBO J., (1993), vol. 12, pages 2855 - 2862
		- KUWAHARA, H.; J. KAMEI; N. NAKAMURA; M. MATSUMOTO; H. INOUE; H. KANAZAWA, "The apoptosis-inducing protein kinase DRAK2 is inhibited in a calcium-dependent manner by the calcium-binding protein CHP", JBIOCHEM., (2003), vol. 134, pages 245 - 250
		- LADNER, C.J.; J. CZECH; J. MAURICE; S.A. LORENS; J.M. LEE, "Reduction of calcineurin enzymatic activity in Alzheimer's disease: correlation with neuropathologic changes", JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, (1996), vol. 55, pages 924 - 931
		- LE ROY, C.; J.L. WRANA, "Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling", NAT REV MOL CELL BIOL., (2005), vol. 6, pages 112 - 126
		- LEFEBVRE, S.; L. BURGLEN; S. REBOULLET; O. CLERMONT; P. BURLET; L. VIOLLET; B. BENICHOU; C. CRUAUD; P. MILLASSEAU; M. ZEVIANI ET A, "Identification and characterization of a spinal muscular atrophy-determining gene", CELL, (1995), vol. 80, pages 155 - 165
		- LIN, X.; R.A. SIKKINK; F. RUSNAK; D.L. BARBER, "Inhibition of calcineurin phosphatase activity by a calcineurin B homologous protein", J BIOL CHEM., (1999), vol. 274, doi:doi:10.1074/jbc.274.51.36125, pages 36125 - 36131, XP002213293 DOI: http://dx.doi.org/10.1074/jbc.274.51.36125
		- LIU, J.; J.D. FARMER, JR.; W.S. LANE; J. FRIEDMAN; I. WEISSMAN; S.L. SCHREIBER, "Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes", CELL, (1991), vol. 66, doi:doi:10.1016/0092-8674(91)90124-H, pages 807 - 815, XP027461712 DOI: http://dx.doi.org/10.1016/0092-8674(91)90124-H
		- LIU, J.O., "Endogenous protein inhibitors of calcineurin", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, (2003), vol. 311, doi:doi:10.1016/j.bbrc.2003.10.020, pages 1103 - 1109, XP004472284 DOI: http://dx.doi.org/10.1016/j.bbrc.2003.10.020
		- LIU, J.P.; A.T. SIM; P.J. ROBINSON, "Calcineurin inhibition of dynamin I GTPase activity coupled to nerve terminal depolarization", SCIENCE, (1994), vol. 265, pages 970 - 973
		- LIU, Y.; H.C. ZAUN; J. ORLOWSKI; S.L. ACKERMAN, "CHPl-mediated NHE1 biosynthetic maturation is required for Purkinje cell axon homeostasis", J NEUROSCI., (2013), vol. 33, pages 12656 - 12669
		- MILLER, N.; Z. FENG; B.M. EDENS; B. YANG; H. SHI; C.C. SZE; B.T. HONG; S.C. SU; J.A. CANTU; J. TOPCZEWSKI, "Non-aggregating tau phosphorylation by cyclin-dependent kinase 5 contributes to motor neuron degeneration in spinal muscular atrophy", J NEUROSCI., (2015), vol. 35, pages 6038 - 6050
		- MURRAY, L.M.; L.H. COMLEY; D. THOMSON; N. PARKINSON; K. TALBOT; T.H. GILLINGWATER., "Selective vulnerability of motor neurons and dissociation of pre- and postsynaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy", HUM MOL GENET., (2008), vol. 17, pages 949 - 962
		- NARYSHKIN, N.A.; M. WEETALL; A. DAKKA; J. NARASIMHAN; X. ZHAO; Z. FENG; K.K. LING; G.M. KARP; H. QI; M.G. WOLL, "Motor neuron disease. SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy", SCIENCE, (2014), vol. 345, pages 688 - 693
		- NOLLE, A.; A. ZEUG; J. VAN BERGEIJK; L. TONGES; R. GERHARD; H. BRINKMANN; S. A1 RAYES; N. HENSEL; Y. SCHILL; D. APKHAZAVA, "The spinal muscular atrophy disease protein SMN is linked to the Rho-kinase pathway via profilin", HUM MOL GENET, (2011), vol. 20, pages 4865 - 4878
		- OPREA, G.E.; S. KROBER; M.L. MCWHORTER; W. ROSSOLL; S. MULLER; M. KRAWCZAK; G.J. BASSELL; C.E. BEATTIE; B. WIRTH, "Plastin 3 is a protective modifier of autosomal recessive spinal muscular atrophy", SCIENCE, (2008), vol. 320, pages 524 - 527
		- PALACINO, J.; S.E. SWALLEY; C. SONG; A.K. CHEUNG; L. SHU; X. ZHANG; M. VAN HOOSEAR; Y. SHIN; D.N. CHIN; C.G. KELLER, "SMN2 splice modulators enhance Ul-pre-mRNA association and rescue SMA mice", NATURE CHEMICAL BIOLOGY, (2015), vol. 11, pages 511 - 517
		- RIESSLAND, M.; B. ACKERMANN; A. FORSTER; M. JAKUBIK; J. HAUKE; L. GARBES; I. FRITZSCHE; Y. MENDE; I. BLUMCKE; E. HAHNEN, "SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy", HUM MOL GENET., (2010), vol. 19, pages 1492 - 1506
		- RIESSLAND, M.; A. KACZMAREK; S. SCHNEIDER; K.J. SWOBODA; H. LOHR; C. BRADLER; V. GRYSKO; M. DIMITRIADI; S. HOSSEINIBARKOOIE; L. TO, "Neurocalcin Delta Suppression Protects against Spinal Muscular Atrophy in Humans and across Species by Restoring Impaired Endocytosis", AMERICAN JOURNAL OF HUMAN GENETICS, (2017), vol. 100, doi:doi:10.1016/j.ajhg.2017.01.005, pages 297 - 315, XP029905981 DOI: http://dx.doi.org/10.1016/j.ajhg.2017.01.005
		- ROBERTS, B.; J. POHL; J.L. GOOCH, "A fluorimetric method for determination of calcineurin activity", CELL CALCIUM, (2008), vol. 43, doi:doi:10.1016/j.ceca.2007.08.004, pages 515 - 519, XP022617112 DOI: http://dx.doi.org/10.1016/j.ceca.2007.08.004
		- SCHREIJ, A.M.; E.A. FON; P.S. MCPHERSON, "Endocytic membrane trafficking and neurodegenerative disease", CELLULAR AND MOLECULAR LIFE SCIENCES : CMLS, (2016), vol. 73, doi:doi:10.1007/s00018-015-2105-x, pages 1529 - 1545, XP035801845 DOI: http://dx.doi.org/10.1007/s00018-015-2105-x
		- SMILLIE, K.J.; M.A. COUSIN, "Akt/PKB controls the activity-dependent bulk endocytosis of synaptic vesicles", TRAFFIC, (2012), vol. 13, pages 1004 - 1011
		- SMITH, D.B.; K.S. JOHNSON, "Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase", GENE, (1988), vol. 67, doi:doi:10.1016/0378-1119(88)90005-4, pages 31 - 40, XP023544179 DOI: http://dx.doi.org/10.1016/0378-1119(88)90005-4
		- TIMM, S.; B. TITUS; K. BERND; M. BARROSO, "The EF-hand Ca(2+)-binding protein p22 associates with microtubules in an N-myristoylation-dependent manner", MOL BIOL CELL, (1999), vol. 10, pages 3473 - 3488
		- WIRTH, B.; M. BARKATS; C. MARTINAT; M. SENDTNER; T.H. GILLINGWATER, "Moving towards treatments for spinal muscular atrophy: hopes and limits", EXPERT OPINION ON EMERGING DRUGS, (2015), vol. 20, doi:doi:10.1517/14728214.2015.1041375, pages 353 - 356, XP055340211 DOI: http://dx.doi.org/10.1517/14728214.2015.1041375
		- WOO, C.J.; V.K. MAIER; R. DAVEY; J. BRENNAN; G. LI; J. BROTHERS, 2ND; B. SCHWARTZ; S. GORDO; A. KASPER; T.R. OKAMOTO, "Gene activation of SMN by selective disruption of lncRNA-mediated recruitment of PRC2 for the treatment of spinal muscular atrophy", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, (2017), vol. 114, doi:doi:10.1073/pnas.1616521114, pages E1509 - E1518, XP055355645 DOI: http://dx.doi.org/10.1073/pnas.1616521114
		- WU, X.S.; Z. ZHANG; W.D. ZHAO; D. WANG; F. LUO; L.G. WU, "Calcineurin is universally involved in vesicle endocytosis at neuronal and nonneuronal secretory cells", CELL REPORTS., (2014), vol. 7, pages 982 - 988

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 34p